Literature DB >> 22322898

Drug release patterns and cytotoxicity of PEG-poly(aspartate) block copolymer micelles in cancer cells.

Allison M Eckman1, Eleftheria Tsakalozou, Nayon Y Kang, Andrei Ponta, Younsoo Bae.   

Abstract

PURPOSE: To test physicochemical and biological properties of PEG-poly(aspartate) [PEG-p(Asp)] block copolymer micelles entrapping doxorubicin hydrochloride (DOX) through ionic interaction.
METHODS: PEG-p(Asp) was synthesized from 5 kDa PEG and 20 Asp units. Carboxyl groups of p(Asp) were present as benzyl ester [PEG-p(Asp/Bz)], sodium salt [PEG-p(Asp/Na)] or free acid [PEG-p(Asp/H)]. Block copolymers and DOX were mixed at various ratios to prepare polymer micelles, which were subsequently characterized to determine particle size, drug loading and release patterns, and cytotoxicity against prostate (PC3 and DU145) and lung (A549) cancer cell lines.
RESULTS: PEG-p(Asp/Bz), Na- and H-micelles entrapped 1.1, 56.8 and 40.6 wt.% of DOX, respectively. Na- and H-micelles (<100 nm) showed time-dependent DOX release at pH 7.4, which was accelerated at pH 5.0. Na-micelles were most stable at pH 7.4, retaining 31.8% of initial DOX for 48 h. Cytotoxicity of Na-micelles was 23.2% (A549), 28.5% (PC3) and 45.9% (DU145) more effective than free DOX.
CONCLUSION: Ionic interaction appeared to entrap DOX efficiently in polymer micelles from PEG-p(Asp) block copolymers. Polymer micelles possessing counter ions (Na) of DOX in the core were the most stable, releasing drugs for prolonged time in a pH-dependent manner, and suppressing cancer cells effectively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322898     DOI: 10.1007/s11095-012-0697-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  44 in total

1.  Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine.

Authors:  Jubo Liu; Yuehua Xiao; Christine Allen
Journal:  J Pharm Sci       Date:  2004-01       Impact factor: 3.534

2.  Nanochannel technology for constant delivery of chemotherapeutics: beyond metronomic administration.

Authors:  Alessandro Grattoni; Haifa Shen; Daniel Fine; Arturas Ziemys; Jaskaran S Gill; Lee Hudson; Sharath Hosali; Randy Goodall; Xuewu Liu; Mauro Ferrari
Journal:  Pharm Res       Date:  2010-07-01       Impact factor: 4.200

Review 3.  Preclinical and clinical studies of anticancer agent-incorporating polymer micelles.

Authors:  Yasuhiro Matsumura; Kazunori Kataoka
Journal:  Cancer Sci       Date:  2009-04       Impact factor: 6.716

Review 4.  Polymeric micelles as a new drug carrier system and their required considerations for clinical trials.

Authors:  Masayuki Yokoyama
Journal:  Expert Opin Drug Deliv       Date:  2010-02       Impact factor: 6.648

Review 5.  Nanoparticle technologies for cancer therapy.

Authors:  Frank Alexis; Eric M Pridgen; Robert Langer; Omid C Farokhzad
Journal:  Handb Exp Pharmacol       Date:  2010

6.  Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance.

Authors:  K Kataoka; T Matsumoto; M Yokoyama; T Okano; Y Sakurai; S Fukushima; K Okamoto; G S Kwon
Journal:  J Control Release       Date:  2000-02-14       Impact factor: 9.776

Review 7.  Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.

Authors:  Kazuo Maruyama
Journal:  Adv Drug Deliv Rev       Date:  2010-10-28       Impact factor: 15.470

8.  Mixed pH-sensitive polymeric micelles for combination drug delivery.

Authors:  Younsoo Bae; Adam W G Alani; Nicole C Rockich; T S Z Chung Lai; Glen S Kwon
Journal:  Pharm Res       Date:  2010-08-11       Impact factor: 4.200

9.  Does a targeting ligand influence nanoparticle tumor localization or uptake?

Authors:  Kathleen F Pirollo; Esther H Chang
Journal:  Trends Biotechnol       Date:  2008-08-21       Impact factor: 19.536

10.  Targeting the DNA double strand break repair machinery in prostate cancer.

Authors:  Fadhel S Shaheen; Pawel Znojek; Ann Fisher; Martin Webster; Ruth Plummer; Luke Gaughan; Graeme C M Smith; Hing Y Leung; Nicola J Curtin; Craig N Robson
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

View more
  6 in total

1.  A Computational/Experimental Assessment of Antitumor Activity of Polymer Nanoassemblies for pH-Controlled Drug Delivery to Primary and Metastatic Tumors.

Authors:  Louis T Curtis; Piotr Rychahou; Younsoo Bae; Hermann B Frieboes
Journal:  Pharm Res       Date:  2016-06-29       Impact factor: 4.200

2.  Comparison of Dialysis- and Solvatofluorochromism-Based Methods to Determine Drug Release Rates from Polymer Nanoassemblies.

Authors:  Derek Reichel; Younsoo Bae
Journal:  Pharm Res       Date:  2016-11-21       Impact factor: 4.200

3.  Pharmaceutical differences between block copolymer self-assembled and cross-linked nanoassemblies as carriers for tunable drug release.

Authors:  Hyun Jin Lee; Younsoo Bae
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

4.  Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells.

Authors:  Chih-Kuang Chen; Wing-Cheung Law; Ravikumar Aalinkeel; Yun Yu; Bindukumar Nair; Jincheng Wu; Supriya Mahajan; Jessica L Reynolds; Yukun Li; Cheng Kee Lai; Emmanuel S Tzanakakis; Stanley A Schwartz; Paras N Prasad; Chong Cheng
Journal:  Nanoscale       Date:  2014       Impact factor: 7.790

Review 5.  Nanoparticle-mediated drug delivery for treating melanoma.

Authors:  Vaibhav Mundra; Wei Li; Ram I Mahato
Journal:  Nanomedicine (Lond)       Date:  2015-08-05       Impact factor: 5.307

6.  Highly photostable nanogels for fluorescence-based theranostics.

Authors:  Dipendra Gyawali; Jimin P Kim; Jian Yang
Journal:  Bioact Mater       Date:  2017-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.